Clinical trial
A Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF
NCT04072315 is registered in ClinicalTrials.gov with Pliant Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2a Evaluation of PLN-74809 on αvβ6 Receptor Occupancy Using PET Imaging in Participants With IPF
- Lead sponsor
- Pliant Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- February 13, 2020
- Completion date
- July 5, 2022
- Enrollment
- 9 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.